Clinical trial
A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
NCT00000936 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00000936 |
|---|---|
| Title | A Study To Test An Anti-Rejection Therapy After Kidney Transplantation |
| Official title | Controlled Trial of Induction Therapy in Renal Transplantation |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | hOKT3, Oral Cyclosporine, IV Cyclosporine |
| Enrollment | 292 |
| Start date | Nov 1, 1999 |
| Completion | Mar 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: